Jeffrey O'Callaghan

8PUBLICATIONS
36CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Vision scienceCentral nervous systemLiquid biopsiesCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 23, 2026
Death receptors regulate entry to therapy-induced senescence and orchestrate addiction to IAPs.

|Sep 23, 2026
Preclinical and clinical evaluation of systemic danegaptide for the treatment of nonproliferative diabetic retinopathy.

|Mar 18, 2026
Blood-brain barrier disruption, traumatic encephalopathy, and cognitive decline in retired athletes.

Chris Greene, Declan Brennan, Sheida Mirloo

|Nov 27, 2024
p53 and the E3 Ubiquitin Ligase MDM2 in Glaucomatous Lamina Cribrosa Cells.

Kealan McElhinney, Mustapha Irnaten, Jeffrey O'Callaghan

|Feb 22, 2024
Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment.

Chris Greene, Ruairi Connolly, Declan Brennan

|Apr 19, 2023
Matrix metalloproteinase-3 (MMP-3)-mediated gene therapy for glaucoma.

Jeffrey O'Callaghan, Conor Delaney, Merissa O'Connor

Pageof 2

Frequent Collaborators

6 joint publications

Matthew Campbell

3 joint publications

Chris Greene

3 joint publications

Colin P Doherty

2 joint publications

Sarah L Doyle